期刊文献+

别嘌呤醇致重症药疹9例临床分析 被引量:1

Clinical Analysis of 9 Cases with Severe Drug Eruption by Allopurinol
下载PDF
导出
摘要 目的探讨别嘌呤醇致重症药疹的临床特点。方法对9例别嘌呤醇致重症药疹患者的临床表现、实验室检查、治疗、预后进行回顾性分析。结果别嘌呤醇所致重症药疹包括重症多形红斑型、表皮坏死松解型、剥脱性皮炎型。潜伏期长、病情急重、肝肾受累常见、糖皮质激素治疗有效,但病程长、死亡率高。结论别嘌呤醇致重症药疹应用皮质类固醇激素治疗时宜早期、足量、足疗程、缓慢减量。 Objective To study of the clinical feature of severe drug eruption by allopurinol. Methods retrospective analysis of 9 cases of severe drug eruption by allopurinol was made in detail ; including clinical situation, laboratory examination, treatment and prognosis. Results Severe drug eruption by allopurinol had four types:erythema multiforme gravis or Steven-Johnson syndrome,epidermal necrolysis and exfoliative dermatitis. It was characterized by long-incubation period, critical situation, hepatic and renal dysfunction, effective response to corticosteroid therapy, long duration and high mortality. Conclusion The principals of corticosteroid therapy in severe drug eruption by allopurinol are early using, sufficient dose, enough duration and gradually reduction.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2007年第9期548-549,共2页 The Chinese Journal of Dermatovenereology
关键词 重症药疹 别嘌呤醇 Allopurinol Serere Drug Eruption Clinical Analysis.
  • 相关文献

参考文献6

  • 1陈磊,潘萌,郑捷.别嘌呤醇所致各型药疹的预后与肾功能的关系[J].中华皮肤科杂志,2000,33(2):102-103. 被引量:54
  • 2Farquhanson CA,Butler R,Hill A,et al.Allopurinol improves endothelial dysfunction in chronic heart failure[J].Ciculation,2002,106(2):221-226.
  • 3沈新.56例别嘌呤醇药疹的临床特征回顾性分析[J].上海第二医科大学学报,2002,22(3):288-288. 被引量:13
  • 4Hamoka H,Mazatani H,Nouchi N,et al.Allopurinol hypersensitivity syndrome hypersensitivity to oxypurinol but not allopurinol[J].Clin EXP Dermatol,1998,23(1):32-34.
  • 5Sullivan JR,Shear NH.The drug hypersensitivity sydrome:What is the pathogenesis?[J].Arch Dermatol,2001,137(3):357-364.
  • 6Hande KR,Noone RM,Stone WJ.Serere allopurinol toxicity.Description and guidelines for prevention in patients with renal insufficiency[J].AMJ.Med,1984,76(1):47-56.

二级参考文献1

共引文献62

同被引文献12

  • 1朱学骏,王宝玺,孙建方,等.皮肤病学[M].第2版,北京:北京大学医学出版社,2011.1476.
  • 2Fiszenson- Albala F, Auzerie V, Mahe E,et al. A 6- monthprospectivesurvey of cutaneous drug reactions in a hospitalsetting[ J] . Br J Dermatol,2003 ,149( 5) :1018- 1022.
  • 3Chave TA,. Mortimer NJ,Sladden MJ,et al. Toxic epider-mal necrolysis : current evidence, practical management andfuture directions [ J ]. The British Journal of Dermatology,2005,153(2) ;241-253.
  • 4Petkov T, Pehlivanov G, Grozdev I,et al. Toxic epidermalnecrolysis as a dermatological manifestation of drug hyper-sensitivity syndrome[ J]. European Journal of Dermatology,2007,17(5) :422427.
  • 5Viard I,Wehrli P,Bullani R, et al. Inhibition of toxic epi-dermal necrolysis by blockade of GD95 with human intrave-nous immunogiobulin[ J]. Science, 1998, 282(5388):490-493.
  • 6Prins C, Kerdel FA, Padilla RS,et al. Treatment of toxicepidermal necrolysis with high-dose intravenous immunoglob-ulins :multicenter retrospective analysis of 48 consecutivecases[ J]. Archives of dermatology,2003, 139(1):26-32.
  • 7Stella M, Clemente A,Bollero D,et al. Toxic epidermalnecrolysis ( TEN) and Stevens-Johnson syndrome ( SJS):experience with high-dose intravenous immunoglobulins andtopical conservative approach. A retrospective analysis [ J }.Journal of International Society for Burn Injuries,2007,33(4) :452-459.
  • 8Mockenhaupt M, Viboud C,Dunant A, et al. Stevens-John-son syndrome and toxic epidermal necrolysis : assessment ofmedication risks with emphasis on recently marketed drugs.The EuroSCAR-study[ J ]. Journal of Investigative Dermatol-ogy, 2008,128(1) :35-44.
  • 9Somkrua R, Eickman EE, Saokaew S, et al. Association ofHLA-B * 5801 allele and allopurinol-induced Stevens Johnsonsyndrome and toxic epidermal necrolysis : a systematic reviewand meta-analysis [ J ]. BMC Medical Genetics, 2011,12:118.
  • 10Maekawa K, Nishikawa J, Kaniwa N, et al. Development ofa Rapid and Inexpensive Assay for Detecting a Surrogate Ge-netic Polymorphism of HLA-B * 5801 : A Partially Predictivebut Useful Biomarker for Allopurinol-related Stevens - JohnsonSyndrome/toxic Epidermal Necrolysis in Japanese[ J]. DrugMetabolism and Pharmacokinetics ,2012, 27(4) :447-450.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部